CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7289 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Blair Hoeting und 1 weiteren Autor:innen. Beteiligte Einrichtung: 1The Ohio State University - College of Medicine, Columbus, OH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1The Ohio State University - College of Medicine, Columbus, OH.
- 2The Ohio State University - James Comprehensive Cancer Center, Columbus, OH.
Zitieren
APA
Hoeting, B., & Johnson, K. C. C. (2026). CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7289
Vancouver
Hoeting B, Johnson KCC. CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7289
BibTeX
@article{Hoeting2026,
author = {Hoeting, Blair and Johnson, Kai Conrad Cecil},
title = {CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7289}
}
EUVIMED